A study in mouse orthotopic models of HNSCC showed that Anti-TIM-3 treatment concomitantly with anti-PD-L1 and radiotherapy led to a significant delay in tumor growth, increased T-cell cytotoxicity, reduced Tregs, and improved survival [106]. The gene discussed is HAVCR2; the disease is head and neck squamous cell carcinoma.